As of 2026-09-20, the Fair Value of HLS Therapeutics Inc (HLS.TO) is -2.29 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.99 CAD, the upside of HLS Therapeutics Inc is -157.35%.
With the market price of 3.99 CAD and our fair value calculation, HLS Therapeutics Inc (HLS.TO) is not a good investment. Investing in HLS.TO stocks now will result in a potential loss of 157.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -13.10 | -23.60 | -27.53 | -19.66 | -12.43 | -19.26 |
| YoY growth | 14.38% | -80.15% | -16.66% | 28.61% | 36.76% | -3.41% |
| Market Cap (mil) | 124.77 |
| P/E | |
| Forward P/E |
| EPS | -0.33 |
| Avg earnings growth rate | -3.41% |
| TTM earnings | -10.29 |